- Home
- CNM vs ELAN Comparison
CNM vs ELAN Comparison
Compare CNM & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- ELAN
- Stock Information
- Founded
- CNM 1996
- ELAN 1954
- Country
- CNM United States
- ELAN United States
- Employees
- CNM N/A
- ELAN N/A
- Industry
- CNM Durable Goods
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- CNM Consumer Discretionary
- ELAN Health Care
- Exchange
- CNM Nasdaq
- ELAN Nasdaq
- Market Cap
- CNM 9.7B
- ELAN 10.3B
- IPO Year
- CNM 2021
- ELAN 2018
- Fundamental
- Price
- CNM $51.94
- ELAN $20.56
- Analyst Decision
- CNM Buy
- ELAN Buy
- Analyst Count
- CNM 11
- ELAN 8
- Target Price
- CNM $60.27
- ELAN $19.14
- AVG Volume (30 Days)
- CNM 3.2M
- ELAN 5.4M
- Earning Date
- CNM 09-09-2025
- ELAN 11-05-2025
- Dividend Yield
- CNM N/A
- ELAN N/A
- EPS Growth
- CNM 7.24
- ELAN N/A
- EPS
- CNM 2.25
- ELAN 0.88
- Revenue
- CNM $7,740,000,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- CNM $4.62
- ELAN $5.72
- Revenue Next Year
- CNM $4.57
- ELAN $4.88
- P/E Ratio
- CNM $23.04
- ELAN $23.36
- Revenue Growth
- CNM 11.02
- ELAN N/A
- 52 Week Low
- CNM $41.64
- ELAN $8.02
- 52 Week High
- CNM $67.18
- ELAN $21.76
- Technical
- Relative Strength Index (RSI)
- CNM 38.37
- ELAN 68.85
- Support Level
- CNM $50.59
- ELAN $20.29
- Resistance Level
- CNM $53.28
- ELAN $21.76
- Average True Range (ATR)
- CNM 1.28
- ELAN 0.58
- MACD
- CNM 0.25
- ELAN 0.01
- Stochastic Oscillator
- CNM 42.80
- ELAN 64.33
About CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.